The first Intercept Pharmaceuticals trade was made in Q1 2014.
Since then Jim Simons bought shares twelve more times and sold shares on eleven occasions. The investor completely sold their stake between Q2 2023 and Q4 2023.
Avg closing price
Price range
Sold -826 Thousand shares
Q4 2023
Avg closing price
$18.76
Price range
$18.20
-
$19.00
Sold 6.1% shares (-53.6 Thousand shares)
Q3 2023
Avg closing price
$11.31
Price range
$9.99
-
$18.71
Sold 16.3% shares (-171 Thousand shares)
Q2 2023
Avg closing price
$13.93
Price range
$9.17
-
$19.29
Increased shares by 48.3% (+342 Thousand shares)
Q1 2023
Avg closing price
$17.30
Price range
$12.53
-
$21.71
Sold 4.2% shares (-30.9 Thousand shares)
Q4 2022
Avg closing price
$14.16
Price range
$11.61
-
$16.11
Increased shares by 87.9% (+346 Thousand shares)
Q3 2022
Avg closing price
$16.10
Price range
$12.21
-
$19.70
Increased shares by 82.8% (+178 Thousand shares)
Q2 2022
Avg closing price
$16.01
Price range
$11.23
-
$19.59
Sold 11.6% shares (-28.4 Thousand shares)
Q1 2022
Avg closing price
$15.66
Price range
$13.37
-
$17.79
Increased shares by 22.0% (+44 Thousand shares)
Q4 2021
Avg closing price
$16.86
Price range
$14.28
-
$19.53
New holding (+200 Thousand shares)
Q3 2021
Avg closing price
$16.00
Price range
$12.99
-
$20.47
Sold -35.6 Thousand shares
Q2 2021
Avg closing price
$19.82
Price range
$15.46
-
$24.50
Sold 91.9% shares (-401 Thousand shares)
Q1 2021
Avg closing price
$27.88
Price range
$19.33
-
$37.75
Increased shares by 78.6% (+192 Thousand shares)
Q4 2020
Avg closing price
$33.14
Price range
$24.48
-
$42.47
Sold 23.6% shares (-75.5 Thousand shares)
Q3 2020
Avg closing price
$45.95
Price range
$39.09
-
$53.44
Increased shares by 4.5% (+13.8 Thousand shares)
Q2 2020
Avg closing price
$77.25
Price range
$46.70
-
$92.04
Increased shares by 232.3% (+214 Thousand shares)
Q1 2020